Glycosaminoglycans: use in treatment of diabetic nephropathy.
Gambaro
Giovanni
G
Dipartimento di Scienze Mediche e Chirurgiche, Divisione di Nefrologia, Policlinico Universitario, Università di Padova, Padova, Italy.
VAN DER Woude
Fokko J
FJ
Vth Medical University Clinic, Klinikum Mannheim, Ruperto Carola University Heidelberg, Mannheim, Germany.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism; D006025:Glycosaminoglycans / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007668:Kidney / Q000187:drug effects; D013997:Time Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D006025:Glycosaminoglycans; D006493:Heparin